Sanofi ADR
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $12,205,000 | $13,170,000 | $10,735,000 | $10,606,000 |
Gross Profit | 8,575,000 | 9,758,000 | 7,743,000 | 7,717,000 |
EBITDA | 3,823,000 | 4,198,000 | 1,889,000 | 2,770,000 |
EBIT | 1,851,000 | 3,737,000 | 1,511,000 | 2,371,000 |
Net Income | -801,000 | 2,802,000 | 3,940,000 | 1,872,000 |
Net Change In Cash | 12,205,000 | 13,170,000 | 10,735,000 | 10,606,000 |
Free Cash Flow | 1,587,000 | 4,595,000 | 42,000 | 2,093,000 |
Cash | 7,657,000 | 8,906,000 | 15,359,000 | 7,991,000 |
Basic Shares | 2,440,800 | 2,467,800 | 2,467,800 | 2,467,800 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $46,716,000 | $44,286,000 | $41,618,000 | $40,561,000 |
Gross Profit | 33,793,000 | 31,081,000 | 28,990,000 | 28,679,000 |
EBITDA | 12,680,000 | 11,033,000 | 11,390,000 | 13,510,000 |
EBIT | 9,470,000 | 7,447,000 | 6,961,000 | 10,402,000 |
Net Income | 7,813,000 | 5,560,000 | 5,400,000 | 8,371,000 |
Net Change In Cash | 46,716,000 | 44,286,000 | 41,618,000 | 40,561,000 |
Free Cash Flow | 8,892,000 | 5,886,000 | 8,639,000 | 8,325,000 |
Cash | 7,657,000 | 7,441,000 | 8,710,000 | 12,736,000 |
Basic Shares | 2,440,800 | 2,502,800 | 2,512,800 | 2,503,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $1.53 |
2025-09-30 | $1.68 |
2025-06-30 | $0.91 |
